Assessing the economic burden of asthma

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 6, 2003, Pages 1203-1204

  Stempel, David A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC RHINITIS; ASTHMA; COHORT ANALYSIS; DATA BASE; ECONOMIC EVALUATION; EDITORIAL; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; LUNG FUNCTION; METHODOLOGY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PRODUCTIVITY;

EID: 0038518174     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1553     Document Type: Editorial

References (8)

1. Cisternas MG, Blanc PD, Yen IH, et al. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunology 2003;111:1212.
2. Stempel DA, O'Donnell JC, Meyer JW. Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs. J Allergy Clin Immunol 2002;109:433-9.
3. Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness in the United States, 1985-1994. J Allergy Clin Immunol 2000;106:493-9.
4. Legorreta AP, Christian-Herman J, O'Connor RD, Hasan MM, Evan R, Leung K-M. Compliance with national asthma guidelines and specialty care. Arch Intern Med 1998;158:457-64.
5. Drummond MF, Richardson S, O'Brien BJ, Levine M, Heyland D. Users' guide to the medical literature XIII. How to use an article on economic analysis. JAMA 1997;277:1552-7.
6. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000;343:1054-63.
7. O'Bryne PM, Barnes PJ, Rodriquez-Roisen R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma. Am J Respir Crit Care Med 2001;164:1392-7.
8. Donahue J, Weiss S, Livingston J, Goetsch MA, Breineder D, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997;277:887-91.